AMP Buys Shares in Paratek Pharmaceuticals (PRTK) in Hypothetical Fund

Last week on February 28, AMP bought a position in Paratek Pharmaceuticals (PRTK) by purchasing 1,672 shares at a price of $14.95/share. The transaction totaled $25,000 with 2.4% of the total fund now allocated to that position.

*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon